These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35332266)

  • 1. Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression.
    Zhao W; Mo H; Liu R; Chen T; Yang N; Liu Z
    Br J Cancer; 2022 Jul; 127(2):202-210. PubMed ID: 35332266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding.
    Lv D; Jia F; Hou Y; Sang Y; Alvarez AA; Zhang W; Gao WQ; Hu B; Cheng SY; Ge J; Li Y; Feng H
    Cancer Res; 2017 Nov; 77(22):6190-6201. PubMed ID: 29021135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP.
    Jin Y; Yang R; Ding J; Zhu F; Zhu C; Xu Q; Cai J
    Biochem Biophys Res Commun; 2021 Dec; 585():185-190. PubMed ID: 34808502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Acetyltransferase 1 Promotes Cell Proliferation and Induces Cisplatin Resistance in Hepatocellular Carcinoma.
    Jin X; Tian S; Li P
    Oncol Res; 2017 Jul; 25(6):939-946. PubMed ID: 27938492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1.
    Liu W; Zhan Z; Zhang M; Sun B; Shi Q; Luo F; Zhang M; Zhang W; Hou Y; Xiao X; Li Y; Feng H
    Theranostics; 2021; 11(13):6278-6292. PubMed ID: 33995658
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.
    Pu J; Wu X; Wu Y; Shao Z; Luo C; Tang Q; Wang J; Wei H; Lu Y
    Aging (Albany NY); 2021 Mar; 13(8):12207-12223. PubMed ID: 33952719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of PD-L1 by Sox2 contributes to the proliferation of hepatocellular carcinoma cells.
    Zhong F; Cheng X; Sun S; Zhou J
    Oncol Rep; 2017 May; 37(5):3061-3067. PubMed ID: 28339084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.
    Zhang Y; Zhang D; Jiang J; Dong L
    Oncol Rep; 2017 Jan; 37(1):323-332. PubMed ID: 27878280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z; Xia X; Lu J
    Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA DANCR promotes colorectal tumor growth by binding to lysine acetyltransferase 6A.
    Lian J; Zhang H; Wei F; Li Q; Lu Y; Yu B; Yu L; Liang X; Wen Y; Jin K; Tang J; Xie W
    Cell Signal; 2020 Mar; 67():109502. PubMed ID: 31863900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer.
    Yu B; Luo F; Sun B; Liu W; Shi Q; Cheng SY; Chen C; Chen G; Li Y; Feng H
    Adv Sci (Weinh); 2021 Oct; 8(20):e2100014. PubMed ID: 34392614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.
    Sharma S; Chung CY; Uryu S; Petrovic J; Cao J; Rickard A; Nady N; Greasley S; Johnson E; Brodsky O; Khan S; Wang H; Wang Z; Zhang Y; Tsaparikos K; Chen L; Mazurek A; Lapek J; Kung PP; Sutton S; Richardson PF; Greenwald EC; Yamazaki S; Jones R; Maegley KA; Bingham P; Lam H; Stupple AE; Kamal A; Chueh A; Cuzzupe A; Morrow BJ; Ren B; Carrasco-Pozo C; Tan CW; Bhuva DD; Allan E; Surgenor E; Vaillant F; Pehlivanoglu H; Falk H; Whittle JR; Newman J; Cursons J; Doherty JP; White KL; MacPherson L; Devlin M; Dennis ML; Hattarki MK; De Silva M; Camerino MA; Butler MS; Dolezal O; Pilling P; Foitzik R; Stupple PA; Lagiakos HR; Walker SR; Hediyeh-Zadeh S; Nuttall S; Spall SK; Charman SA; Connor T; Peat TS; Avery VM; Bozikis YE; Yang Y; Zhang M; Monahan BJ; Voss AK; Thomas T; Street IP; Dawson SJ; Dawson MA; Lindeman GJ; Davis MJ; Visvader JE; Paul TA
    Cell Chem Biol; 2023 Oct; 30(10):1191-1210.e20. PubMed ID: 37557181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling.
    Xie W; Zhang Y; Wang B; Hu Y; Zhan B; Wei F; Tang J; Lian J
    Cancer Med; 2020 Sep; 9(17):6367-6376. PubMed ID: 32677374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway.
    Zhang X; Shao J; Li X; Cui L; Tan Z
    Oncol Rep; 2019 Feb; 41(2):1067-1074. PubMed ID: 30483804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology.
    Wiesel-Motiuk N; Assaraf YG
    Drug Resist Updat; 2020 Dec; 53():100729. PubMed ID: 33130515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Expression of Histone Acetyltransferase KAT6A in Non-small Cell Lung Cancer.
    Partynska A; Piotrowska A; Pawelczyk K; Rzechonek A; Ratajczak-Wielgomas K; Podhorska-Okolow M; Dziegiel P
    Anticancer Res; 2022 Dec; 42(12):5731-5741. PubMed ID: 36456139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBO1 overexpression is important for hepatocellular carcinoma cell growth.
    Zhong W; Liu H; Deng L; Chen G; Liu Y
    Cell Death Dis; 2021 May; 12(6):549. PubMed ID: 34039960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth.
    Baell JB; Leaver DJ; Hermans SJ; Kelly GL; Brennan MS; Downer NL; Nguyen N; Wichmann J; McRae HM; Yang Y; Cleary B; Lagiakos HR; Mieruszynski S; Pacini G; Vanyai HK; Bergamasco MI; May RE; Davey BK; Morgan KJ; Sealey AJ; Wang B; Zamudio N; Wilcox S; Garnham AL; Sheikh BN; Aubrey BJ; Doggett K; Chung MC; de Silva M; Bentley J; Pilling P; Hattarki M; Dolezal O; Dennis ML; Falk H; Ren B; Charman SA; White KL; Rautela J; Newbold A; Hawkins ED; Johnstone RW; Huntington ND; Peat TS; Heath JK; Strasser A; Parker MW; Smyth GK; Street IP; Monahan BJ; Voss AK; Thomas T
    Nature; 2018 Aug; 560(7717):253-257. PubMed ID: 30069049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-645 represses hepatocellular carcinoma progression by inhibiting SOX30-mediated p53 transcriptional activation.
    Tao J; Liu Z; Wang Y; Wang L; Yin G; Yang W; Tu K; Liu Q
    Int J Biol Macromol; 2019 Jan; 121():214-222. PubMed ID: 30312695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.